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Abstract
Background: Mutations in several potassium channel subunits have been associated with rare
forms of atrial fibrillation. In order to explore the role of potassium channels in inherited typical
forms of the arrhythmia, we have screened a cohort of patients from a referral clinic for mutations
in the channel subunit genes implicated in the arrhythmia. We sought to determine if mutations in
KCNJ2 and KCNE1-5 are a common cause of atrial fibrillation.
Methods: Serial patients with lone atrial fibrillation or atrial fibrillation with hypertension were
enrolled between June 1, 2001 and January 6, 2005. Each patient underwent a standardized
interview and physical examination. An electrocardiogram, echocardiogram and blood sample for
genetic analysis were also obtained. Patients with a family history of AF were screened for
mutations in KCNJ2 and KCNE1-5 using automated sequencing.
Results: 96 patients with familial atrial fibrillation were enrolled. Eighty-three patients had lone
atrial fibrillation and 13 had atrial fibrillation and hypertension. Patients had a mean age of 56 years
at enrollment and 46 years at onset of atrial fibrillation. Eighty-one percent of patients had
paroxysmal atrial fibrillation at enrollment. Unlike patients with an activating mutation in KCNQ1,
the patients had a normal QTc interval with a mean of 412 ± 42 ms. Echocardiography revealed a
normal mean ejection fraction of 62.0 ± 7.2 % and mean left atrial dimension of 39.9 ± 7.0 mm. A
number of common polymorphisms in KCNJ2 and KCNE1-5 were identified, but no mutations
were detected.
Conclusion: Mutations in KCNJ2 and KCNE1-5 rarely cause typical atrial fibrillation in a referral
clinic population.
Background
Atrial fibrillation (AF) is the most common clinical
arrhythmia and accounts for approximately 3% of all
medical admissions [1]. It is a major source of morbidity
and mortality, due to chronic medication use, stroke and
congestive heart failure[2,3]. While much is known of the
mechanisms of AF initiation and maintenance[4], the
molecular basis of variation in susceptibility to the
arrhythmia is not known.
The identification of extended families with AF, and the
mapping of discrete genetic loci in such families have
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raised the possibility that the biologic mechanisms under-
lying predisposition to the arrhythmia are accessible [5-7].
The first gene for AF was identified in a Chinese family
with a persistent form of the arrhythmia. A mutation was
found in the first transmembrane spanning domain
(S140G) of the potassium channel gene, KCNQ1[8], pre-
viously implicated as a cause of Long QT syndrome, type
1 (LQT1). The majority of affected family members in the
AF kindred exhibited no structural heart disease, but 3
patients were noted to have mild left ventricular dysfunc-
tion, and 9 of the 16 affected individuals had a prolonged
QT interval. In cardiac myocytes, KCNQ1 associates with
β subunits, such as KCNE1, to form the potassium chan-
nel carrying the IKs current. Co-expression of the S140G
mutant form of KCNQ1 with KCNE1 in COS-7 cells
caused increased current density, as well as enhancement
of channel activation and inactivation. These observations
contrast with the consistent reduction in current density
seen with those KCNQ1 mutations associated with LQT1,
and also with the significant prolongation of the QT inter-
val seen in many of the individuals in the AF family. This
paradoxical result may reflect unique chamber-specific
effects of the mutation or coupling of the channel with
different partner proteins, but also serves to emphasize
that our understanding of repolarization is incomplete. A
second gain-of-function mutation in the KCNQ1 gene has
since been found to cause AF in a child before birth, and
in this case occurred along with the expected shortening
of the QT interval[9]. Despite these two reports, muta-
tions in KCNQ1 are an uncommon cause of AF in a typical
population with the lone form of the arrhythmia[10].
Mutations in two other potassium channel subunit genes
have been reported in association with AF. A single muta-
tion in the KCNE2 gene, which encodes an β subunit com-
mon to both IKs and IKr complexes, was described in two
patients with familial AF[11]. This sequence alteration
partly segregated with disease in two kindreds and was not
found in a large number of ethnically matched controls.
In vitro data suggest that the sequence alteration (R27C)
results in increased KCNQ1–KCNE2 inward and outward
currents. Of note, this putative gain of function mutation
would be predicted to shorten action potential duration,
an electrophysiologic effect likely to favor the initiation
and maintenance of AF. Another putative mutation in the
KCNJ2 gene has been associated with isolated familial
AF[12]. In this instance there is segregation of the muta-
tion with the disease in a single kindred and there are in
vitro data supporting a gain of function effect on the Kir
2.1 channel. While these data appear to strengthen the
case for a common mechanism linking potassium chan-
nels with AF, the sequence alteration described results in
a relatively conservative change at an amino acid level
(V93I), and this very sequence is found in wild-type
KCNJ2 protein in lower species suggesting that it may be
a rare polymorphism. In addition, AF has been associated
with rare gain of function mutations in KCNQ1, hERG
and KCNJ2 causing the short QT syndrome and sudden
death.
Interestingly, mice null for KCNE1 exhibit spontaneous
AF implying at the very least a more complex mechanism
than simple changes in ion conductance as the link
between potassium channel genes and this arrhythmia.
There are multiple KCNE isoforms, many, if not all, of
which are expressed in the heart and thus are potential
candidates for such a disease mechanism.
While a major genetic contribution to lone AF is clear,
identifying the causal genes is likely to be an arduous
task[10,13,14]. The paroxysmal and often asymptomatic
nature of the phenotype usually precludes the identifica-
tion of unaffected individuals and restricts many studies
to affecteds only approaches, while overt genetic heteroge-
neity limits strategies based on aggregation of families.
The small numbers of extended kindreds available restrict
mapping studies and formal positional cloning efforts. In
the face of these obstacles, direct sequencing in patient
cohorts is the only feasible approach at present to confirm
or refute potential candidate genes. We sought to deter-
mine whether mutations in KCNJ2 and KCNE1-5 play any
role in more typical forms of this arrhythmia by screening
a cohort of 96 patients with a family history of AF in at
least one relative.
Methods
Clinical evaluation
All studies were performed with Institutional Review
Board approval at Massachusetts General Hospital. Prior
to any study procedures, written informed consent was
obtained from the study patient. Serial patients with lone
AF or AF/HTN referred to the arrhythmia service were
enrolled between June 1, 2001 and January 6, 2005. Inclu-
sion criteria were AF documented by electrocardiography,
and an age less than or equal to 65 years. The exclusion
criteria were structural heart disease as assessed by
echocardiography, rheumatic heart disease, hyperthy-
roidism, myocardial infarction, or congestive heart fail-
ure.
Each patient underwent a physical examination and a
standardized interview to identify past medical condi-
tions, medications, symptoms and possible triggers for
initiation of AF. The medical history of all first-degree rel-
atives was also obtained. All patients were evaluated by
12-lead electrocardiogram (EKG), echocardiogram, and
laboratory studies. Electrocardiograms and echocardio-
grams were interpreted using standard criteria.BMC Medical Genetics 2006, 7:70 http://www.biomedcentral.com/1471-2350/7/70
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From the cohorts with lone AF or AF/HTN, those patients
reporting a family history of AF (a total of 96 individuals)
underwent further genetic studies.
Mutation detection
A blood sample (16 ml.) was obtained in acid citrate dex-
trose from every patient for the extraction of DNA. The
isolation of DNA was performed directly from the original
blood sample, or from a stable EBV-transformed lym-
phoblastoid cell line derived from this sample, using the
Puregene DNA Purification Kit (Gentra Systems, Inc.,
Minneapolis, MN). Oligonucleotide primers for the cod-
ing regions of each gene were designed using the known
cDNA and genomic sequence as follows:
KCNE1 (BC046224): CTTTAAGAGGTGTGCCTGGG,
AATGTGATTAGAAAATCAGGTTGC,
KCNE2 (AF302095): CCGTTTTCCTAACCTTGTTCG,
GACAATTTGGATTTGCCTCG,
KCNE3 (NM005472.3): ACAGCCAAACCATATCAGCC,
ACGACCTCCCTTAACCGTG,
KCNE4(NM080671): GTTCCACAAACCTCGTGCTC,
CCGCACTGTGAAAGTGAAAC,
KCNE5 (NM012282): GCTAGCTCGCTTCCCCTC,
GAACCCTGGAAGGGAGTTG
KCNJ2(AF153820): Amplicon 1: CGAACATTCAAAACT-
GTTTCTCC, ACAGCAATTGGGCATT
CATC, Amplicon 2: TCCGAGGTCAACAGCTTCAC
CCATGCCTTCCAGTATGACC, Amplicon 3: TCTGGT-
GTCCCCAATCAC,
GGGCCTCTGACCAACAGAC.
PCR was performed under the following conditions: 30–
50 ng of genomic DNA was subjected to 35 cycles of
amplification in a volume of 25 uL including 10 mM Tris
HCl (pH 8.3), 50 mM KCl, 1.5 mM MgCl2, 200 mM
dNTP, and 0.2 U Taq polymerase. For sequencing, PCR
products were purified, and 25–50 ng of DNA was
sequenced directly by use of the ABI PRISM dye termina-
tor method (Model 377, Applied Biosystems, Foster City,
California, USA). The gene structure, size and amplicons
are illustrated in Figure 1.
Statistical analyses
Continuous variables were tested for normality of distri-
bution and two-sided t-tests were used for comparisons of
means. The χ2 test was used for categorical variables. P val-
ues of 0.05 or less were considered significant. All statisti-
cal analyses were performed using Intercooled STATA
version 8.0.
Results
During the study period a total of 252 patients with lone
AF and 43 with AF/HTN were enrolled. From this total
cohort, 83 patient with lone AF (33%) and 13 patients
with AF/HTN (30%) reported a family history of AF in at
least one first-degree relative. The clinical characteristics of
these 96 patients are summarized in Table 1. The mean
age at onset of AF was 46 years, and the age at enrollment
was 56 years. Eighty-one percent of patients had paroxys-
mal AF at enrollment. The electrocardiograms of the study
patients were notable for a normal mean PR of 176 ± 32.0
ms, QRS of 95.6 ± 15.3 ms, and QTc intervals of 412 ±
41.8 ms. Echocardiography of the study cohort revealed a
mildly enlarged mean left atrial size of 39.9 ± 7.0 mm and
a normal left ventricular ejection fraction, 62.0 ± 7.2 %.
The coding sequence of KCNJ2 and KCNE1-5 was
screened for mutations by direct sequencing (Figure 1).
While 17 polymorphisms were identified, no disease
causing mutations were found (Table 2). Of the three pol-
ymorphisms that resulted in change in the protein
sequence, all were found to be present in control popula-
tions.
Size and Structure of the KCNE1-5 and KCNJ2 genes Figure 1
Size and Structure of the KCNE1-5 and KCNJ2 genes. Thin 
lines represent introns while exons are depicted as boxes. 
Small boxes are non-coding regions and large boxes are cod-
ing regions. Arrows indicate the location of PCR primers. 
The genomic size of each gene is presented to the right of 
each figure.
65,585 bp KCNE1
7,118 bp
5,233 bp KCNE3
1,702 bp KCNE4
KCNE5 1,463 bp
KCNJ2 10,506 bp
KCNE2
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Discussion
Potassium channel gene mutations resulting in increased
repolarizing currents and shorter action potential dura-
tion are highly plausible as a cause of AF. Work in several
large animal models has identified action potential short-
ening as one of the earliest effects of AF itself, and this
'electrical remodeling' is known to be a major factor in the
maintenance of the arrhythmia and in its tendency to
recur. In this context the identification of 'activating'
mutations in the KCNQ1 gene in families with inherited
forms of AF rapidly led to speculation that primary abnor-
malities of cardiac potassium currents might represent a
common mechanism for the arrhythmia, and stimulated
the search for mutations in other potassium channel sub-
unit genes in affected individuals. Following up on previ-
ous isolated reports of mutations in the potassium
channel subunit genes, KCNJ2 and KCNE1 we screened a
cohort of 96 unrelated individuals with familial AF and
found no evidence of causal KCNJ2 and KCNE1-5 muta-
tions in 96 unrelated individuals. These data effectively
exclude mutations in the KCNJ2 and KCNE1-5 gene as
common causes of AF, and suggest that those families that
do have mutations at this locus are unlikely to exhibit typ-
ical AF phenotypes.
Four polymorphisms that we identified resulted in an
alteration of the coding sequence. The D85N variant of
KCNE1 has previously been reported to decrease the IKs
current when co-expressed with KCNQ1 [15]. The R83H
variant of KCNE3 was described in an individual with
hypokalemic periodic paralysis; however, this variant was
found in three of our patients none of whom had any
prior episodes of paralysis and thus it appears likely that
this is a rare polymorphism [16]. The functional effects of
the E145D variant of KCNE4 and the P33S variant of
KCNE5 are unknown.
While the genetic evidence supporting KCNQ1 mutations
as a cause of AF is reasonably strong, in many of the other
reported associations between AF and potassium channel
gene mutations the absence of segregation data, the pri-
vate nature of most of the sequence abnormalities
described and inconsistent electrophysiologic findings all
contribute to continued uncertainty. There are many
potential reasons for these findings. Potassium channel
gene mutations may simply represent a very rare cause of
AF. However, it is also possible that the reported muta-
tions are not acting through changes in ion channel con-
ductance, but rather through other mechanisms, which
may be shared across forms of AF. For example, the organ-
ization of the KCNQ1 genomic locus is only beginning to
be understood, and effects on regional transcription or tis-
sue-specific imprinting must be considered in addition to
potential interactions within large multi-protein channel
complexes. Finally, it is conceivable that the reported
mutations in potassium channel genes are not causal in
AF, but rather are genetically linked to the true causal
Table 2: Observed polymorphisms in potassium channels.
Gene Exon Polymorphism Allele 
frequency
Reference
KCNE1 1 G84A, S28S 0.0052 [17]
1 G112A, G38S 0.24 [18]
1 C158T, F53F 0.11
1 C240T, V80V 0.021 [19]
1G 2 5 3 A ,   D85N 0.021 [15], [20]
1 G37A, Q13Q 0.0052
KCNE3 1 T198C, F66F 0.09 [21]
1 G248A, R83H 0.016 [16]
KCNE4 1 T81C, G27G 0.31
1 G69A, S23S 0.005
1 C264T, P88P 0.098
1 G435T, E145D 0.32
1 G471A, E157E 0.031
1 3'+18, G>C 0.073
KCNE5 1 C97T, P33S 0.25
1 C207T, F69F 0.021
KCNJ2 3 C1146T, L383L 0.13
These are numbered based on the ATG using the cDNA sequence 
KCNE1 (BC046224), KCNE2 (AF302095), KCNE3 (NM005472.3), 
KCNE4 (NM080671), KCNE5 (NM012282), KCNJ2 (AF153820). 
Lower case letters refer to intronic base pairs and are located with 
respect to the corresponding intron-exon boundaries (5' or 3' +/- 
number of basepairs). Upper case letters refer to exonic 
polymorphisms. Polymorphisms that change the coding sequnce are 
indicated in bold. No polymorphisms were identified in KCNE2.
Table 1: Baseline characteristics of the study cohort.
Mean ± SD or n (Percentage)
Total 96
Age at enrollment (years) 56.1 ± 10.3
Age at onset of AF (years) 46.3 ± 12.2
Paroxysmal AF 78 (81.3)
Heart rate (bpm) 67 ± 14.1 bpm
Systolic blood pressure (mmHg) 126.3 ± 23.4
Diastolic blood pressure (mmHg) 77.3 ± 9.5
Electrocardiogram
PR interval (ms) 176 ± 32.0
QRS interval (ms) 95.6 ± 15.3
QTc interval (ms) 412 ± 41.8
Echocardiogram
Left atrial size (mm) 39.9 ± 7.0
Ejection fraction (percent) 62.0 ± 7.2
Ethnicity
Caucasian 92 (96)
African-American 1 (1)
Asian 1 (1)
American Indian 1 (1)
Middle Eastern 1 (1)BMC Medical Genetics 2006, 7:70 http://www.biomedcentral.com/1471-2350/7/70
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genes. Ultimately, the identification of the causal genes in
those rare families large enough for successful positional
cloning efforts will offer insights into the true role of
potassium channel genes in this disorder.
The current study has several intrinsic limitations. The
cohort we studied was derived from referrals to an aca-
demic medical center and therefore may not be reflective
of all cohorts with lone AF. Additionally, since our
patients were recruited from a population of predomi-
nantly Northern European descent, mutations in potas-
sium channel genes may still have a role in other
ethnically groups.
Conclusion
Mutations in potassium channels, KCNJ2 and KCNE1-5,
rarely cause typical atrial fibrillation in a referral clinic
population.
Abbreviations
AF Atrial fibrillation
EKG Electrocardiogram
LQT1 Long QT syndrome, Type 1
Competing interests
The author(s) declare that they have no competing inter-
ests.
Authors' contributions
VIP, EAZ and EGN carried out the molecular genetic stud-
ies and performed the sequence analysis. PTE and CAM
conceived of the study, and participated in its design and
coordination, and wrote the manuscript. All authors read
and approved the final manuscript.
Acknowledgements
This project is supported by NIH awards to Dr. Ellinor (HL71632) and Dr. 
MacRae (HL75431).
References
1. Chugh SS, Blackshear JL, Shen WK, Hammill SC, Gersh BJ: Epidemi-
ology and natural history of atrial fibrillation: clinical implica-
tions.  J Am Coll Cardiol 2001, 37:371-378.
2. Wolf PA, Abbott RD, Kannel WB: Atrial fibrillation: a major con-
tributor to stroke in the elderly. The Framingham Study.
Arch Intern Med 1987, 147:1561-1564.
3. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy
D: Impact of atrial fibrillation on the risk of death: the Fram-
ingham Heart Study.  Circulation 1998, 98:946-952.
4. Nattel S: New ideas about atrial fibrillation 50 years on.  Nature
2002, 415:219-226.
5. Oberti C, Wang L, Li L, Dong J, Rao S, Du W, Wang Q: Genome-
wide linkage scan identifies a novel genetic locus on chromo-
some 5p13 for neonatal atrial fibrillation associated with sud-
den death and variable cardiomyopathy.  Circulation 2004,
110:3753-3759.
6. Ellinor PT, Shin JT, Moore RK, Yoerger DM, MacRae CA: Locus for
atrial fibrillation maps to chromosome 6q14-16.  Circulation
2003, 107:2880-2883.
7. Brugada R, Tapscott T, Czernuszewicz GZ, Marian AJ, Iglesias A,
Mont L, Brugada J, Girona J, Domingo A, Bachinski LL, Roberts R:
Identification of a genetic locus for familial atrial fibrillation.
N Engl J Med 1997, 336:905-911.
8. Chen YH, Xu SJ, Bendahhou S, Wang XL, Wang Y, Xu WY, Jin HW,
Sun H, Su XY, Zhuang QN, Yang YQ, Li YB, Liu Y, Xu HJ, Li XF, Ma
N, Mou CP, Chen Z, Barhanin J, Huang W: KCNQ1 gain-of-func-
tion mutation in familial atrial fibrillation.  Science 2003,
299:251-254.
9. Hong K, Piper DR, Diaz-Valdecantos A, Brugada J, Oliva A, Burash-
nikov E, Santos-de-Soto J, Grueso-Montero J, Diaz-Enfante E, Brugada
P, Sachse F, Sanguinetti MC, Brugada R: De novo KCNQ1 muta-
tion responsible for atrial fibrillation and short QT syndrome
in utero.  Cardiovasc Res 2005, 68:433-440.
10. Ellinor PT, Moore RK, Patton KK, Ruskin JN, Pollak MR, Macrae CA:
Mutations in the long QT gene, KCNQ1, are an uncommon
cause of atrial fibrillation.  Heart 2004, 90:1487-1488.
11. Yang Y, Xia M, Jin Q, Bendahhou S, Shi J, Chen Y, Liang B, Lin J, Liu Y,
Liu B, Zhou Q, Zhang D, Wang R, Ma N, Su X, Niu K, Pei Y, Xu W,
Chen Z, Wan H, Cui J, Barhanin J: Identification of a KCNE2 gain-
of-function mutation in patients with familial atrial fibrilla-
tion.  Am J Hum Genet 2004, 75:899-905.
12. Xia M, Jin Q, Bendahhou S, He Y, Larroque MM, Chen Y, Zhou Q,
Yang Y, Liu Y, Liu B, Zhu Q, Zhou Y, Lin J, Liang B, Li L, Dong X, Pan
Z, Wang R, Wan H, Qiu W, Xu W, Eurlings P, Barhanin J: A Kir2.1
gain-of-function mutation underlies familial atrial fibrilla-
tion.  Biochem Biophys Res Commun 2005, 332:1012-1019.
13. Darbar D, Herron KJ, Ballew JD, Jahangir A, Gersh BJ, Shen WK,
Hammill SC, Packer DL, Olson TM: Familial atrial fibrillation is a
genetically heterogeneous disorder.[comment].  Journal of the
American College of Cardiology 2003, 41:2185-2192.
14. Fox CS, Parise H, D'Agostino RB Sr, Lloyd-Jones DM, Vasan RS, Wang
TJ, Levy D, Wolf PA, Benjamin EJ: Parental atrial fibrillation as a
risk factor for atrial fibrillation in offspring.  Jama 2004,
291:2851-2855.
15. Westenskow P, Splawski I, Timothy KW, Keating MT, Sanguinetti
MC: Compound mutations: a common cause of severe long-
QT syndrome.  Circulation 2004, 109:1834-1841.
16. Silva MR, Chiamolera MI, Kasamatsu TS, Cerutti JM, Maciel RM:
[Thyrotoxic hypokalemic periodic paralysis, an endocrine
emergency: clinical and genetic features in 25 patients].  Arq
Bras Endocrinol Metabol 2004, 48:196-215.
17. Jongbloed R, Marcelis C, Velter C, Doevendans P, Geraedts J, Smeets
H: DHPLC analysis of potassium ion channel genes in con-
genital long QT syndrome.  Hum Mutat 2002, 20:382-391.
18. Lai LP, Deng CL, Moss AJ, Kass RS, Liang CS: Polymorphism of the
gene encoding a human minimal potassium ion channel
(minK).  Gene 1994, 151:339-340.
19. Lloyd EA, Gersh BJ, Forman R: The efficacy of quinidine and dis-
opyramide in the maintenance of sinus rhythm after electro-
conversion from atrial fibrillation. A double-blind study
comparing quinidine, disopyramide and placebo.  S Afr Med J
1984, 65:367-369.
20. Gouas L, Nicaud V, Berthet M, Forhan A, Tiret L, Balkau B, Guicheney
P: Association of KCNQ1, KCNE1, KCNH2 and SCN5A pol-
ymorphisms with QTc interval length in a healthy popula-
tion.  Eur J Hum Genet 2005, 13:1213-1222.
21. Doi K, Sato T, Kuramasu T, Hibino H, Kitahara T, Horii A, Matsushiro
N, Fuse Y, Kubo T: Meniere's disease is associated with single
nucleotide polymorphisms in the human potassium channel
genes, KCNE1 and KCNE3.  ORL J Otorhinolaryngol Relat Spec
2005, 67:289-293.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2350/7/70/prepub